Results 41 to 50 of about 43,790 (213)
Molecular-genetic study of the RA-27/3 strain used for production of rubella vaccine
Журнал микробиологии, эпидемиологии и иммунобиологии, 2019 Aim. In order to study rubella virus strain RA-27/3 genetic stability, used for the vaccines production, a molecular genetic study was conducted. Materials and methods. In the study different series of master and work seed of RA-27/3 rubella virus strain
G. M. Ignatev +4 more
doaj +1 more source
Duration of Immunity After Rubella Vaccination: A Long-Term Study in Switzerland [PDF]
, 2017 In Switzerland 319 of 594 young women seronegative for rubella antibody vaccinated at 15-25 years of age against rubella with the Cendehill vaccine strain were retested 15 years later with three tests (hemagglutination inhibition, enzyme-linked ...
Berger, Rosemarie +4 more
core
On Pediatric Vaccines and Catholic Social Teaching [PDF]
, 2018 Determining whether, and when, to get one\u27s children vaccinated has become an increasingly controversial decision, often leaving parents fearful of making the “wrong” choice.
Bilgrien +20 more
core +2 more sources
Journal of Advanced Nursing, EarlyView.ABSTRACT Aim To examine the American Cancer Society's HPV vaccination guidelines through a nursing policy analysis framework, assessing justice and equity outcomes in cancer prevention policy implementation. Background Human papillomavirus vaccination remains critical for cancer prevention, yet persistent health disparities undermine equity goals ...
Grace K. Kyei +2 more
wiley +1 more source
Vaccines, 2020 Background: age structured mathematical models have been used to evaluate the impact of rubella-containing vaccine (RCV) introduction into existing measles vaccination programs in several countries. South Africa has a well-established measles vaccination
Nkengafac Villyen Motaze +4 more
doaj +1 more source
The “Reducing Inflammation for Greater Health Trial (RIGHT)” Study—Concept, Rationale, and Design
Journal of the American Geriatrics Society, EarlyView.ABSTRACT The Reducing Inflammation for Greater Health Trial's (RIGHT) study is a single‐center, randomized, double‐blind, placebo‐controlled trial designed to test whether clazkizumab, an interleukin‐6 (IL‐6) inhibitor, can improve or slow decline in physical, cognitive, and vascular function in older adults, when compared to a placebo.
Sebastian E. Sattui +11 more
wiley +1 more source
Clinical Epidemiology and Global Health, 2021 Background: The immunization coverage progress in India is relatively slower than anticipated. The rising internet and media penetration and online news contents are likely to shape the public vaccine sentiments and attitude.
Manoja Kumar Das +2 more
doaj +1 more source
Immune response to vaccines in children with celiac disease [PDF]
, 2017 Celiac disease (CD) is an immune-mediated systemic condition evoked by ingestion of gluten and related prolamines in genetically susceptible subjects. The disease is featured by a variable combination of clinical signs, specific antibodies, HLA-DQ2 and ...
ANANIA, Caterina +4 more
core +1 more source
Public Health Nursing, EarlyView.ABSTRACT Objective To estimate vaccination coverage (VC) and analyze the factors associated with the incomplete vaccination schedule (IVS) in children under 5 years of age in two Basic Health Units in the Federal District of Brazil. Design A cross‐sectional study.
Ivea Rayane Mendes Nicacio Viana +1 more
wiley +1 more source
Rubella immunity among pregnant women aged 15–44 years, Namibia, 2010
International Journal of Infectious Diseases, 2016 Background: The level of rubella susceptibility among women of reproductive age in Namibia is unknown. Documenting the risk of rubella will help estimate the potential burden of disease in Namibian women and the risk of congenital rubella syndrome (CRS ...
Anna Jonas +14 more
doaj +1 more source